Fennec Pharmaceuticals (FENC) Net Margin (2020 - 2025)

Fennec Pharmaceuticals (FENC) posted Net Margin of 34.22% for Q4 2025, down 584.44% on a QoQ basis from 5.0% in Q3 2025, and down 1528.0% year-over-year from 2.4% in Q4 2024.

Fennec Pharmaceuticals (FENC) Net Margin (2020 - 2025) Analysis & Trends

Fennec Pharmaceuticals' Net Margin history runs 4 years deep, the most recent figure standing at 34.22% for Q4 2025.

  • Quarterly Net Margin fell 1528.0% year-over-year to 34.22% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 21.63% (down 2201.0% YoY) and the FY2025 annual result came in at 13.9%, down 1069.0% from the prior year.
  • Net Margin was 34.22% for Q4 2025 at Fennec Pharmaceuticals, down from 5.0% in the prior quarter.
  • Across five years, Net Margin topped out at 50.86% in Q1 2024 and bottomed at 355.34% in Q1 2023.
  • A 3-year average of 65.18% and a median of 29.94% in 2023 frame the typical range for Net Margin.
  • Annual changes were most pronounced in 2024 — Net Margin surged 40619 bps — and 2025, when it slumped 6416 bps.
  • Fennec Pharmaceuticals' Net Margin stood at 26.89% in 2023, then grew by 30 bps to 18.94% in 2024, then slumped by 81 bps to 34.22% in 2025.
  • Business Quant data shows FENC's Net Margin at 34.22% in Q4 2025, 5.0% in Q3 2025, and 32.69% in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 15.02%
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 34.53%
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 20.17%
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn 28.20%
9 Revolution Medicines 37.37 Bn 37.37 Bn - -
10 Fennec Pharmaceuticals 287.77 Mn 250.98 Mn 12.01 Mn -34.22%

Historic Data

Download Data
DateValue
Dec 31, 2025 -34.22%
Sep 30, 2025 -5.00%
Jun 30, 2025 -32.69%
Mar 31, 2025 -13.30%
Dec 31, 2024 -18.94%
Sep 30, 2024 -81.89%
Jun 30, 2024 -75.92%
Mar 31, 2024 50.86%
Dec 31, 2023 -26.89%
Sep 30, 2023 -27.18%
Jun 30, 2023 -161.68%
Mar 31, 2023 -355.34%
Dec 31, 2020 -17,240.00%